Exchange: NASDAQ·Updated 03:44 PM EDT
ARDX logo

ARDX Ardelyx Inc

$3.82
$0.08
(2.14%)
Today
Reported EarningsAug 6
Mkt Cap$931.96M
Vol1.84M

About ARDX

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.
51

Neutral Sentiment

How do you feel about ARDX?

Advertisement|Remove ads.